| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
159,210,000 |
| Market
Cap: |
1.03(B) |
| Last
Volume: |
2,204,422 |
Avg
Vol: |
2,198,480 |
| 52
Week Range: |
$2.76 - $7.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Spiegler Cornel C |
Chief Financial Officer |
• – – |
2004-06-07 |
4 |
B |
$3.13 |
$112,500 |
D/D |
36,000 |
46,750 |
2.74 |
- |
|
| Hsiao Charles |
Director |
– • – |
2004-06-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
300,000 |
4,585,207 |
|
- |
|
| Chu May |
Senior VP - Quality Affairs |
• – – |
2004-06-01 |
4 |
B |
$18.64 |
$1,995 |
D/D |
107 |
64,946 |
2.66 |
- |
|
| Hsiao Charles |
Director |
– • – |
2004-06-01 |
4 |
B |
$18.64 |
$1,995 |
D/D |
107 |
4,285,314 |
2.31 |
- |
|
| Hsu Larry |
President |
• • – |
2004-06-01 |
4 |
B |
$18.64 |
$1,995 |
D/D |
107 |
2,050,116 |
2.73 |
- |
|
| Edwards David J |
Director |
– • – |
2004-05-20 |
5 |
A |
$0.00 |
$0 |
D/D |
26,415 |
49,615 |
|
- |
|
| Burr Robert L |
Director |
– • – |
2004-05-20 |
4 |
A |
$24.70 |
$967,005 |
D/D |
39,150 |
39,150 |
|
- |
|
| Burr Robert L |
Director |
– • – |
2004-05-20 |
4 |
A |
$24.70 |
$149,608 |
D/D |
6,057 |
19,657 |
|
- |
|
| Edwards David J |
Director |
– • – |
2004-05-13 |
4 |
S |
$21.98 |
$1,550,645 |
I/I |
(70,548) |
0 |
|
- |
|
| Edwards David J |
Director |
– • – |
2004-05-12 |
4 |
S |
$21.84 |
$583,181 |
I/I |
(26,700) |
70,548 |
|
- |
|
| J P Morgan Chase & Co |
10% Owner |
– – • |
2004-05-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,922,398) |
263,839 |
|
- |
|
| Hsu Larry |
President |
• • – |
2004-03-03 |
4 |
B |
$19.19 |
$1,996 |
D/D |
104 |
2,650,009 |
2.73 |
- |
|
| Chu May |
VP - Quality Affairs |
• – – |
2004-03-03 |
4 |
B |
$19.19 |
$1,996 |
D/D |
104 |
62,839 |
2.66 |
- |
|
| Hsiao Charles |
Chairman |
• • – |
2004-03-03 |
4 |
B |
$19.19 |
$1,996 |
D/D |
104 |
4,885,207 |
2.73 |
- |
|
| Chu May |
VP - Quality Affairs |
• – – |
2004-02-27 |
4 |
S |
$21.50 |
$64,500 |
I/I |
(3,000) |
49,654 |
|
- |
|
| Chu May |
VP - Quality Affairs |
• – – |
2004-02-26 |
4 |
S |
$20.80 |
$125,400 |
I/I |
(6,000) |
52,654 |
|
- |
|
| Chu May |
VP - Quality Affairs |
• – – |
2004-02-25 |
4 |
S |
$19.25 |
$335,755 |
I/I |
(17,000) |
58,654 |
|
- |
|
| Chu May |
VP - Quality Affairs |
• – – |
2004-02-23 |
4 |
S |
$19.00 |
$95,600 |
I/I |
(5,000) |
75,654 |
|
- |
|
| Edwards David J |
Director |
– • – |
2004-02-19 |
4 |
B |
$7.42 |
$80,763 |
I/I |
10,883 |
97,248 |
2.1 |
- |
|
| J P Morgan Chase & Co |
10% Owner |
– – • |
2004-02-19 |
4 |
OE |
$0.00 |
$0 |
I/I |
538,556 |
5,922,398 |
|
- |
|
| Chu May |
Vice President-Quality Affairs |
• – – |
2004-02-03 |
4 |
S |
$19.50 |
$39,000 |
I/I |
(2,000) |
80,654 |
|
- |
|
| Chu May |
Vice President-Quality Affairs |
• – – |
2004-02-02 |
4 |
S |
$19.20 |
$19,200 |
I/I |
(1,000) |
82,654 |
|
- |
|
| J P Morgan Chase & Co |
10% Owner |
– – • |
2004-01-30 |
4 |
B |
$0.00 |
$0 |
I/I |
1,500,000 |
5,383,842 |
1.42 |
- |
|
| Chu May |
Vice President - Quality Affai |
– • – |
2003-12-01 |
4 |
B |
$11.90 |
$2,000 |
D/D |
168 |
62,735 |
2.31 |
- |
|
| Hsu Larry |
President |
• • – |
2003-12-01 |
4 |
B |
$11.90 |
$2,000 |
D/D |
168 |
2,649,905 |
2.73 |
- |
|
531 Records found
|
|
Page 21 of 22 |
|
|
0.05 (0.76%) 
